EPISODE · Aug 20, 2023 · 37 MIN
Special Report: SynsorMed with Theo Harvey
from The New Era Woman Network · host AWE MEDIA GROUP
SynsorMed is revolutionizing chronic disease management by utilizing telehealth, remote patient monitoring, and analytics to personalize care and reduce readmissions, effectively moving towards value-based care models. Their use of telehealth allows for virtual appointments, remote patient monitoring tracks vital signs, and analytics identifies trends and potential issues before they become significant problems. By providing more personalized care and reducing the likelihood of readmissions, SynsorMed is improving patient outcomes and reducing the overall cost of care.https://www.synsormed.com/Also, stay connected with the Color of Wellness, www.colorofwellness.coBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-new-era-woman-network--4771294/support.Your Media Home for Women of Faith, Wellness, and Leadership.www.NewEraWoman.org2026 Copyright
What this episode covers
SynsorMed is revolutionizing chronic disease management by utilizing telehealth, remote patient monitoring, and analytics to personalize care and reduce readmissions, effectively moving towards value-based care models. Their use of telehealth allows for virtual appointments, remote patient monitoring tracks vital signs, and analytics identifies trends and potential issues before they become significant problems. By providing more personalized care and reducing the likelihood of readmissions, SynsorMed is improving patient outcomes and reducing the overall cost of care.https://www.synsormed.com/Also, stay connected with the Color of Wellness, www.colorofwellness.coBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-new-era-woman-network--4771294/support.Your Media Home for Women of Faith, Wellness, and Leadership.www.NewEraWoman.org2026 Copyright
NOW PLAYING
Special Report: SynsorMed with Theo Harvey
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m